Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. - Wikidata - wikimedia - TriplyDB

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

http://www.wikidata.org/entity/Q46383598

about

The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia.Is YKL-40 a new therapeutic target in cancer?Gene Encoding Chitinase 3-Like 1 Protein (CHI3L1) is a Putative Oncogene Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Immune system disturbances in schizophrenia.Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study Heterogeneity of microglial activation in the innate immune response in the brain.Plasma YKL-40: a potential new cancer biomarker?Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.The significance of YKL-40 protein in liver fibrosis.Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases.YKL-40 acts as an angiogenic factor to promote tumor angiogenesis.YKL-40 expression could be a poor prognostic marker in the breast cancer tissue.CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.Plasma YKL-40 in Inuit and Danes.Plasma YKL-40: a potential biomarker for psoriatic arthritis?Plasma YKL-40, a new biomarker for atrial fibrillation?Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy.Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial.Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease.

P2860

Q24292760-24E43849-FC99-434B-91ED-D95D95738984 Q24595527-F3FB2955-7405-4600-A7E5-291A5909CFC7 Q26781833-D2F5AEF2-173B-4208-847B-009351DAF918 Q26998561-0A2C9EE8-C273-44C3-96DC-88AC6C7CF07B Q28533586-95F0A432-6475-4839-A74D-4C56E4E2F3AD Q28743561-3D58C9C2-527B-4A11-B98F-9A021804B00D Q30417011-A16D670F-D5D1-4139-8DD3-4A7B647300FE Q30447546-5BB37D5B-926D-4C55-88DC-52D82638A28B Q33255102-88CA1A09-1CEA-42DC-A2EC-48BAC78CA54A Q33584262-F937F29E-2B4C-438E-AE72-D9D8A8C299EF Q33719157-8A04183F-4891-47C3-B8C5-9D2DAE6692D5 Q33965057-11D1D07E-037F-47D0-83FA-9D2A64A91CB0 Q34806348-AB6CC212-F27A-4D30-B56F-B25A02046D5D Q35581445-325BFF12-0C70-401B-ACF0-38BED901967D Q35616574-EEF9286B-62D1-4157-84D7-F981C4674820 Q36709555-6AACF49E-B7B7-4509-B151-5014AABE8AFC Q36735677-0DC09073-8A32-4F8A-847B-B23A686A843E Q36913222-D8D085EE-5195-4AE4-8E3D-03B6D7EAE60B Q37334247-02D0FEB2-410F-465A-8529-BF359705EEEE Q37344544-1142AD6A-2A7C-468B-9DC4-867F39D75C21 Q37537572-9EB57982-D601-46FC-9A5A-E7BFBC8D01AD Q37548804-EC9FA32B-92FB-4A24-A180-580C6AA8CC0E Q37572598-059354BB-801F-4B23-899A-22ACA2A8C429 Q37605869-1D027703-6D52-4F2F-B0B2-4D6E6B51C7D0 Q37807414-1AAA8611-62D8-4F58-8AF3-2B328069BBC1 Q38179983-76170B0E-7899-4F9F-A21B-D87497C1404F Q38726476-5D8ED13D-C3E7-46C7-9547-E3CBC80F2977 Q38836316-C347ED88-C371-4A52-A11B-51F75E5F3409 Q41073254-8DBA2566-72F5-4AA6-91DA-AAA1D3B46FF5 Q42442642-5860A4B4-A99D-48AC-83BD-351C3DE58C38 Q43053159-608A38E4-9781-447A-AD6A-5B7AE907238B Q43183960-49193E88-8929-4CB1-9BA4-D161401D86F1 Q44510075-61C55CF9-FEDC-4700-8E6F-6D3F2E889CF0 Q45919537-220C9C24-7038-4FB2-86EA-20012B002F8A Q46359710-1CD0D727-717C-4D7C-A18B-851A476A4376 Q47892929-13877990-8843-4E6B-AF17-8CEEE54C00CC Q48910491-D887936E-2E49-4DC4-8975-3E1CC3085997 Q50231992-88BAFEAC-A3BB-4B6F-9302-016E8A4CBA0B Q50293199-530D195D-DC14-4F37-AE0A-83DC22122C7D Q50802846-7829B0C6-04FD-4BA9-BC0C-8C5F246BBD62

P2860

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

http://www.wikidata.org/entity/Q46383598

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@en

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@nl

type

label

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@en

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@nl

prefLabel

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@en

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@nl

P1433

Q46383598-763F798E-C83F-4980-9C8A-19A5E47E4C84

P1476

Q46383598-7B837DDA-DFA9-4C48-93B7-C232BADAC73A

P2093

Q46383598-26113BEA-5D43-4474-A16C-D7370278A49D

Q46383598-49EC34DE-E594-44B3-85AE-25E1AC86C7C3

Q46383598-8C5EBFC2-DE30-40AE-BB6A-49CE4E7BDEBB

Q46383598-8E19DFB2-7A46-4765-8E46-3D5D11DB5110

Q46383598-AAA9210A-2230-4947-B911-B74D34487F59

P2860

Q46383598-0E5224AA-CFF8-4359-A764-9FF80D90DF2C

Q46383598-0F8FD8C6-62A0-4F21-8473-DCA94D10605F

Q46383598-1268A8D0-EC2A-487C-AB2B-FB50B146EB3C

Q46383598-28962AC8-97ED-4F56-8357-76A8C0E12359

Q46383598-2AF44848-30BB-4819-851C-4C7A392D6812

Q46383598-2B3AF078-3EA3-4EC8-9DD0-2182E794F7B7

Q46383598-33FFEF2E-476C-4A38-AB86-8993281F03F6

Q46383598-383A8827-7701-432D-AAE9-6B92D9BEE60A

Q46383598-3ABC0776-6A0D-498E-87E3-CA5279E395BC

Q46383598-44AC6BD1-04DA-49A0-8B9E-65244BE883B7

P304

Q46383598-F1A0137C-B67A-4B9A-9DE9-471A35C1EBA6

P31

Q46383598-EFCB5337-498E-4791-8514-D82861A7B842

P356

Q46383598-B2F02277-7D1C-458F-A548-2E6D8015F51A

P433

Q46383598-8B0402E0-07DF-4465-BDEF-84C18BCFE653

P478

Q46383598-F2945329-7676-4F07-A1AD-09FA9A62B157

P577

Q46383598-02BEFCBE-D219-4BCF-8A3A-2871F48D755B

P5875

Q46383598-F1E83AB5-DCFA-4761-8305-D8D7C962A7EB

P698

Q46383598-E729F22E-057A-4509-AA34-127BF83068DF

P356

J.1349-7006.2005.00026.X

P1433

P1476

Regulation of YKL-40 expressio ...... s in human glioblastoma cells.

@en

P2093

Eva L Lund

http://www.w3.org/2001/XMLSchema#string

Julia S Johansen

http://www.w3.org/2001/XMLSchema#string

Lasse T Hansen

http://www.w3.org/2001/XMLSchema#string

Nanna Junker

http://www.w3.org/2001/XMLSchema#string

Paul E G Kristjansen

http://www.w3.org/2001/XMLSchema#string

P2860

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes

Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period

The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways

Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution

Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39

Targeting HIF-1 for cancer therapy

YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization

P304

183-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2005.00026.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7962505

http://www.w3.org/2001/XMLSchema#string

P698

15771622

http://www.w3.org/2001/XMLSchema#string